Table of Content

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Musculoskeletal Disorders Drugs Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Musculoskeletal Disorders Drugs Market Analysis
4.1. Market Portraiture
4.2. Market Type
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Musculoskeletal Disorders Drugs Market by Type
5.1. Introduction
5.2. Analgesics
5.3. Corticosteroids
5.4. DMARDs
5.5. Other Types
6. Global Musculoskeletal Disorders Drugs Market by Route of Administration
6.1. Introduction
6.2. Oral
6.3. Parenteral
7. Global Musculoskeletal Disorders Drugs Market by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Providers
7.4. Drug Stores and Retail Pharmacies
8. Global Musculoskeletal Disorders Drugs Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. AbbVie Inc.
12.2.2. Amgen Inc.
12.2.3. AstraZeneca plc
12.2.4. Bristol-Myers Squibb Company
12.2.5. Eli Lilly and Company
12.2.6. GlaxoSmithKline plc
12.2.7. Johnson & Johnson
12.2.8. Merck & Co., Inc.
12.2.9. Novartis AG
12.2.10. Pfizer Inc.
12.2.11. Roche Holding AG
12.2.12. Sanofi S.A.
?

List of Figures

Figure 1: Global Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 2: Global Musculoskeletal Disorders Drugs Market by Type, 2023
Figure 3: Global Musculoskeletal Disorders Drugs Market by Route of Administration, 2023
Figure 4: Global Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023
Figure 5: Global Musculoskeletal Disorders Drugs Market by Region, 2023
Figure 6: Global Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 7: Global Musculoskeletal Disorders Drugs Market by Type (in %), 2023 & 2033
Figure 8: Global Analgesics Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 9: Global Analgesics Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 10: Global Corticosteroids Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 11: Global Corticosteroids Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 12: Global DMARDs Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 13: Global DMARDs Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 14: Global Other Types Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 15: Global Other Types Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 16: Global Musculoskeletal Disorders Drugs Market by Route of Administration (in %), 2023 & 2033
Figure 17: Global Oral Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 18: Global Oral Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 19: Global Parenteral Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 20: Global Parenteral Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 21: Global Musculoskeletal Disorders Drugs Market by Distribution Channel (in %), 2023 & 2033
Figure 22: Global Hospital Pharmacies Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 23: Global Hospital Pharmacies Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 24: Global Online Providers Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 25: Global Online Providers Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 26: Global Drug Stores and Retail Pharmacies Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 27: Global Drug Stores and Retail Pharmacies Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 28: Global Musculoskeletal Disorders Drugs Market by Region (in %), 2023 & 2033
Figure 29: Europe Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 30: Europe Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 31: Europe Musculoskeletal Disorders Drugs Market by Country (in %), 2023 & 2033
Figure 32: Germany Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 33: United Kingdom Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 34: France Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 35: Italy Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 36: Spain Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 37: Russia Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 38: Netherlands Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 39: North America Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 40: North America Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 41: North America Musculoskeletal Disorders Drugs Market by Country (in %), 2023 & 2033
Figure 42: United States Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 43: Canada Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 44: Asia Pacific Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 45: Asia Pacific Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 46: Asia Pacific Musculoskeletal Disorders Drugs Market by Country (in %), 2023 & 2033
Figure 47: China Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 48: Japan Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 49: India Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 50: South Korea Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 51: Australia Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 52: Indonesia Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 53: Latin America Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 54: Latin America Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 55: Latin America Musculoskeletal Disorders Drugs Market by Country (in %), 2023 & 2033
Figure 56: Mexico Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 57: Brazil Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 58: Argentina Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 59: Middle East & Africa Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2023
Figure 60: Middle East & Africa Musculoskeletal Disorders Drugs Market (in US$ Million), 2024-2033
Figure 61: Middle East & Africa Musculoskeletal Disorders Drugs Market by Country (in %), 2023 & 2033
Figure 62: Saudi Arabia Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 63: Turkey Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 64: Iran Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 65: UAE Musculoskeletal Disorders Drugs Market (in US$ Million), 2019-2033
Figure 66: Market Value Chain


List of Tables

Table 1: Global Musculoskeletal Disorders Drugs Market Portraiture
Table 2: Global Musculoskeletal Disorders Drugs Market by Type (in US$ Million), 2023 & 2033
Table 3: Global Musculoskeletal Disorders Drugs Market by Route of Administration (in US$ Million), 2023 & 2033
Table 4: Global Musculoskeletal Disorders Drugs Market by Distribution Channel (in US$ Million), 2023 & 2033
Table 5: Global Musculoskeletal Disorders Drugs Market by Region (in US$ Million), 2023 & 2033
Table 6: Europe Musculoskeletal Disorders Drugs Market by Country (in US$ Million), 2023 & 2033
Table 7: North America Musculoskeletal Disorders Drugs Market by Country (in US$ Million), 2023 & 2033
Table 8: Asia Pacific Musculoskeletal Disorders Drugs Market by Country (in US$ Million), 2023 & 2033
Table 9: Latin America Musculoskeletal Disorders Drugs Market by Country (in US$ Million), 2023 & 2033
Table 10: Middle East & Africa Musculoskeletal Disorders Drugs Market by Country (in US$ Million),
2023 & 2033
Table 11: List of Key Players